Sample size in cluster-randomized trials with time to event as the primary endpoint

Statistics in Medicine

Volumn 32, Issue 5, 2013, Pages 739-751

  Jahn Eimermacher, Antje ^a   Ingel, Katharina ^a   Schneider, Astrid ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Cluster randomized; Correlated; Sample size; Survival; Time to event

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; CLUSTER ANALYSIS; DATA ANALYSIS; EXPERIMENTAL DESIGN; FOLLOW UP; HAZARD RATIO; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; PROBABILITY; RANDOMIZATION; SAMPLE SIZE; STATISTICAL DISTRIBUTION; SYSTEMATIC ERROR; TOTAL QUALITY MANAGEMENT;

BIOSTATISTICS; CLUSTER ANALYSIS; ENDPOINT DETERMINATION; HUMANS; LIKELIHOOD FUNCTIONS; MODELS, STATISTICAL; POISSON DISTRIBUTION; RANDOM ALLOCATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; SAMPLE SIZE; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; TIME-TO-TREATMENT;

EID: 84873466862     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.5548     Document Type: Article

References (36)

1. Donner A, Klar N. Design and Analysis of Cluster Randomization Trials in Health Research. John Wiley & Sons: Hoboken, NJ, 2000.
2. Richard E, vanden Heuvel E, Mollvan Charante E, Achthoven L, Vermeulen M, Bindels P, van Gool W. Prevention of dementia by intensive vascular care (prediva): a cluster-randomized trial in progress. Alzheimer Disease and Associated Disorders 2009; 22:198-204.
3. Gwadry-Sridhar F, Guyatt G, O'Brien B, Arnold J, Walter S, Vingilis E, MacKeigan L. TEACH: trial of education and compliance in heart dysfunction chronic disease and heart failure (HF) as an increasing problem. Contemporary Clinical Trials 2008; 29:905-918.
4. vander Feltz-Cornelis C, Hoedeman R, deJong F, Meeuwissen J, Drewes H, vander Laan N, Adér H. Faster return to work after psychiatric consultation for sicklisted employees with common mental disorders compared to care as usual. A randomized clinical trial. Neuropsychiatric Disease and Treatment 2010; 6:375-385.
5. Fine M, Stone R, Lave J, Hough L, Obrosky D, Mor M, Kapoor W. Implementation of an evidence-based guideline to reduce duration of intravenous antibiotic therapy and length of stay for patients hospitalized with community-acquired pneumonia: a randomized controlled trial. The American Journal of Medicine 2003; 115:343-351.
6. Brotons C, Soriano N, Moral I, Rodrigo M, Kloppe P, Rodríguez A, González M, Ariño D, Orozco D, Buitrago F, Pepío J, Borrás I, StudyResearch Team PREseAP. Randomized clinical trial to assess the efficacy of a comprehensive programme of secondary prevention of cardiovascular disease in general practice: the PREseAP study. Revista Española de Cardioloǵia 2011; 64:13-20.
7. Müller-Nordhorn J, Wegscheider K, Nolte C, Jungehülsing G, Rossnagel K, Reich A, Roll S, Villringer A, Willich S. Population-based intervention to reduce prehospital delays in patients with cerebrovascular events. Archives of Internal Medicine 2009; 169:1484-1490.
8. Quanbeck A, Gustafson D, Ford J, Pulvermacher A, French M, McConnell K, McCarty D. Disseminating quality improvement: study protocol for a large cluster-randomized trial. Implementation Science 2011; 6:44.
9. Hoffman K, Ford J, Tillotson C, Choi D, McCarty D. Days to treatment and early retention among patiens in treatment for alcohol and drug disorders. Addictive Behaviors 2011; 36:643-647.
10. Wienke A. Frailty Models in Survival Analysis. Chapman & Hall/CRC: Boca Raton, 2010.
11. Therneau T, Grambsch P. Modeling Survival Data. Springer: New York, 2000.
12. Zhang H, Schaubel D, Kalbfleisch J. Proportional hazards regression for the analysis of clustered survival data from case-cohort studies. Biometrics 2011; 67:18-28.
13. Ha I, Sylvester R, Legrand C, MacKenzie G. Frailty modelling for survival data from multi-centre clinical trials. Statistics in Medicine 2011; 30:2144-2159.
14. Wienke A, Ripatti S, Palmgren J, Yashin A. A bivariate survival model with compound Poisson frailty. Statistics in Medicine 2010; 29:275-283.
15. Hayes R, Bennett S. Simple sample size calculation for cluster-randomized trials. International Journal of Epidemiology 1999; 28:319-326.
16. Feng S, Wolfe R, Port F. Frailty survival model analysis of the national deceased donor kidney transplant dataset using Poisson variance structures. Journal of the American Statistical Association 2005; 100:728-735.
17. Schoenfeld D. Sample size formula for the proportional-hazards regression model. Biometrics 1983; 39:499-503.
18. Hirsch K, Wienke A, Kuss O. Log-normal frailty models fitted as Poisson generalized linear mixed models: new evidence from simulations. Annual Conference of the German Society of Medical Informatics, Biometrics and Epidemiology (GMDS), 2011.
19. Freedman L. Tables of the number of patients required in clinical trials using the logrank test. Statistics in Medicine 1982; 1:121-129.
20. Hsieh F. Comparing sample size formulae for trials with unbalanced allocation using the logrank test. Statistics in Medicine 1992; 11:1091-1098.
21. Hsu L, Gorfine M, Malone K. On robustness of marginal regression coefficient estimates and hazard functions in multivariate survival analysis of family data when the frailty distribution is mis-specified. Statistics in Medicine 2007; 26:4657-4678.
22. Campbell M. Cluster randomized trials in general (family) practice research. Statistical Methods in Medical Research 2000; 9:81-94.
23. Roudsari B, Fowler R, Nathens A. Intracluster correlation coefficient in multicenter childhood trauma studies. Injury Prevention: Journal of the International Society for Child and Adolescent Injury Prevention 2007; 13:344-347.
24. Therneau T, original Splus→R portby ThomasLumley. Survival: survival analysis, including penalised likelihood, 2011. http://CRAN.R-project.org/package=survival, R package version 2.36-9.
25. Murray D, Varnell S, Blitstein J. Design and analysis of group-randomized trials: a review of recent methodological developments. American Journal of Public Health 2004; 94:423-432.
26. Lin D, Wei L. The robust inference for the Cox proportional hazards model. Journal of the American Statistical Association 1989; 84:1074-1078.
27. van Breukelen G, Candel M. Comments on 'Efficiency loss because of varying cluster size in cluster randomized trials is smaller than literature suggests'. Statistics in Medicine 2012; 31:397-400.
28. Xie T, Waksman J. Design and sample size estimation in clinical trials with clustered survival times as the primary endpoint. Statistics in Medicine 2003; 22:2835-2846.
29. Lee E, Wei L, Amato D. Cox-type regression analysis for large number of small groups of correlated failure time observations. In Survival Analysis: State of the Art, Klein JP, Goel PK (eds). Kluwer Academic Publishers: Dordrect, 1992.
30. McCarty D, Gustafson D, Wisdom J, Ford J, Choi D, Molfenter T, Capoccia V, Cotter F. The network for the improvement of addiction treatment (NIATx): enhancing access and retention. Drug and Alcohol Dependence 2007; 88:138-145.
31. Gangnon R, Kosorok M. Sample-size formula for clustered survival data using weighted log-rank statistics. Biometrika 2004; 91:263-275.
32. Campbell M, Donner A, Klar N. Developments in cluster randomized trials and Statistics in Medicine. Statistics in Medicine 2007; 26:2-19.
33. Jung S, Jeong J. Rank tests for clustered survival data. Lifetime Data Analysis 2003; 9:21-33.
34. Friede T, Kieser M. Sample size recalculation in internal pilot study designs: a review. Biometrical Journal 2006; 48:537-555.
35. Lake S, Kammann E, Klar N, Betensky R. Sample size re-estimation in cluster randomization trials. Statistics in Medicine 2002; 21:1337-1350.
36. Glidden D, Vittinghoff E. Modelling clustered survival data from multicentre clinical trials. Statistics in Medicine 2004; 23:369-388.